Publication:
IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma

Simple item page
dc.contributor.authorGÜLER, Beril
dc.contributor.authorÇAKIR, FATMA BETÜL
dc.contributor.authorCay, A.
dc.contributor.authorMirapoglu, S.
dc.contributor.authorTurkmen, A. Vehaboglu
dc.contributor.authorAki, H.
dc.contributor.institutionauthorÇAKIR, FATMA BETÜL
dc.contributor.institutionauthorGÜLER, BERIL
dc.contributor.institutionauthorÇAY, ALI
dc.date.accessioned2020-04-09T20:59:12Z
dc.date.available2020-04-09T20:59:12Z
dc.date.issued2018-11-01T00:00:00Z
dc.identifier.citationÇAKIR F. B. , GÜLER B., Cay A., Mirapoglu S., Turkmen A. V. , Aki H., -IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma-, PEDIATRIC BLOOD & CANCER, cilt.65, 2018
dc.identifier.urihttps://hdl.handle.net/20.500.12645/16302
dc.identifier.wosWOS:000445195001206
dc.language.isoen
dc.titleIRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
dc.typeArticle
dspace.entity.typePublication
local.avesis.id0cb302ba-a0ea-42b1-8a29-805eb0dd12e0
local.indexed.atWOS
local.publication.isinternational1
relation.isAuthorOfPublication4b01ee0e-c087-44d4-9581-4d73032d078e
relation.isAuthorOfPublicationfee8c5f9-2d88-41e7-8d6d-87789705739a
relation.isAuthorOfPublication28be09fc-1b74-40b6-a69e-55cbf052b2dc
relation.isAuthorOfPublication.latestForDiscovery4b01ee0e-c087-44d4-9581-4d73032d078e

Files

Collections

Yayınlar - Eserler